Sagimet Biosciences Ratios (2023-2024) | SGMT

Ratios Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024
Profitability
EBT Margin -317.85%
EBIT Margin -372.60%
EBITDA Margin -317.65%
Operating Margin -372.60%
Net Margin -317.85%
FCF Margin -193.95%
Efficiency
Assets Average 62.21M99.82M145.62M191.77M181.90M
Equity Average -50.27M94.47M140.54M186.66M176.99M
Invested Capital -198.41M97.88M91.06M190.02M183.29M170.68M
Leverage & Solvency
Equity Ratio -9.230.950.940.980.970.98
Valuation
Enterprise Value -18.51M99.46M29.20M-20.73M-57.23M-63.30M
Market Capitalization 201.30M124.10M172.97M109.15M89.18M